Unleashing the potential of DNA and RNA based therapies using AI
| Round | Date | Amount |
|---|---|---|
| — | 2026-10-06 | $23M |
<a href="https://steek.live/companies/1288"><img src="https://api.steek.live/scoreboard/company/1288/badge.svg" alt="Steek Score" width="248" height="64" /></a>| Company | Raised | Score |
|---|---|---|
| Numerion Labs Artificial intelligence for drug discovery. | — | 17 |
| Verge Genomics We use human data and AI to develop better drugs faster. | — | 17 |
| Helix Nanotechnologies Next-generation mRNA platform to solve cancer, COVID and climate. | — | 17 |
| Macromoltek Computational antibody design | — | 17 |
| Synkrino Biotherapeutics Synkrino's AI, SATIS is a powerful, unbiased discovery system for… | — | 17 |
| Arpeggio Bio Arpeggio Bio develops drugs targeting transcription factors using AI… | — | 17 |
| Abalone Bio We create activating antibodies to treat diseases others can’t. | — | 17 |
| Trident Bioscience Accelerating protein engineering. | — | 17 |
| PostEra Medicinal Chemistry powered by Machine Learning | — | 17 |
| Menten AI Menten AI designs peptide and protein therapeutics using quantum… | — | 17 |
WhiteLab Genomics has a Steek Score of 57 (Emerging) — a transparent 0–100 momentum index built from funding, traction and attention signals.
WhiteLab Genomics operates in drug discovery and delivery, where it ranks #1 of 30 by Steek Score.
WhiteLab Genomics has raised $23M (2026-10-06).
Top competitors include Numerion Labs, Verge Genomics, Helix Nanotechnologies.
WhiteLab Genomics is based in Paris, Île-de-France, France.
Steek Score is a transparent momentum index computed from tracked public signals. Not investment advice.